Artiva Long Term Debt vs Net Invested Capital Analysis
ARTV Stock | 11.04 0.64 6.15% |
Artiva Biotherapeutics, financial indicator trend analysis is way more than just evaluating Artiva Biotherapeutics, prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Artiva Biotherapeutics, is a good investment. Please check the relationship between Artiva Biotherapeutics, Long Term Debt and its Net Invested Capital accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Artiva Biotherapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Long Term Debt vs Net Invested Capital
Long Term Debt vs Net Invested Capital Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Artiva Biotherapeutics, Long Term Debt account and Net Invested Capital. At this time, the significance of the direction appears to have strong relationship.
The correlation between Artiva Biotherapeutics,'s Long Term Debt and Net Invested Capital is 0.77. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Net Invested Capital in the same time period over historical financial statements of Artiva Biotherapeutics, Common, assuming nothing else is changed. The correlation between historical values of Artiva Biotherapeutics,'s Long Term Debt and Net Invested Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Artiva Biotherapeutics, Common are associated (or correlated) with its Net Invested Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Invested Capital has no effect on the direction of Long Term Debt i.e., Artiva Biotherapeutics,'s Long Term Debt and Net Invested Capital go up and down completely randomly.
Correlation Coefficient | 0.77 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Long Term Debt
Long-term debt is a debt that Artiva Biotherapeutics, has held for over one year. Long-term debt appears on Artiva Biotherapeutics, Common balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Artiva Biotherapeutics, Common balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.Net Invested Capital
The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.Most indicators from Artiva Biotherapeutics,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Artiva Biotherapeutics, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Artiva Biotherapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. Selling General Administrative is likely to climb to about 14.3 M in 2024, whereas Tax Provision is likely to drop slightly above 68.8 K in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 248K | 1.2M | 2.3M | 2.4M | Total Operating Expenses | 55.3M | 64.8M | 64.2M | 55.7M |
Artiva Biotherapeutics, fundamental ratios Correlations
Click cells to compare fundamentals
Artiva Biotherapeutics, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Artiva Stock Analysis
When running Artiva Biotherapeutics,'s price analysis, check to measure Artiva Biotherapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artiva Biotherapeutics, is operating at the current time. Most of Artiva Biotherapeutics,'s value examination focuses on studying past and present price action to predict the probability of Artiva Biotherapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artiva Biotherapeutics,'s price. Additionally, you may evaluate how the addition of Artiva Biotherapeutics, to your portfolios can decrease your overall portfolio volatility.